MDNAF — Medicenna Therapeutics Corp.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1807983 ·
Last close
$0.31
Market Cap
$26.14M
52W High
$0.69
52W Low
$0.30
ADV30
89,533
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | — | -5,616,000 | -4,364,000 | 13,065,000 | 10,614,000 | 6,853,000 |
| Sep 2025 | 0 | — | -5,470,000 | -4,883,000 | 18,041,000 | 15,748,000 | 7,799,000 |
| Jun 2025 | 0 | — | -5,509,000 | -4,928,000 | 22,770,000 | 20,459,000 | 8,129,000 |
| Mar 2025 | 0 | — | -5,719,000 | 1,187,000 | 28,382,000 | 24,837,000 | 9,287,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-18,444,000
Investing CF
$2,000
Financing CF
$-18,000
CapEx
$-2,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.24
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-132,427,000
Inventory
—
Receivables
$1,465,000
ST Investments
—
EBIT TTM
$-22,314,000
Pretax Income TTM
$-12,988,000
Interest Exp TTM
—
Analysts
2
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2025 | 0 | -20,406,000 | -11,805,000 | 28,382,000 | 9,287,000 | — | -16,492,000 |
| Mar 2024 | 0 | -18,674,000 | -25,466,000 | 19,134,000 | 13,943,000 | — | -16,260,000 |
| Mar 2023 | 0 | -16,303,000 | -10,048,000 | 36,446,000 | 6,960,000 | — | -12,657,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.17
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TPST | Tempest Therapeutics, Inc. | $26.21M | $1.77 | — |
| CELU | Celularity Inc | $25.96M | $0.90 | — |
| PTN | PALATIN TECHNOLOGIES INC | $25.70M | $14.44 | — |
| OTLC | Oncotelic Therapeutics, Inc. | $26.67M | $0.06 | — |
| ALLR | Allarity Therapeutics, Inc. | $26.81M | $1.68 | — |
News headlines (Yahoo Finance, 1h cache)
Medicenna Announces the Filing of its Prospectus Supplement and Investment Term Sheet
2026-05-22 11:00 · Yahoo
Medicenna Announces the Finalization of the Terms of its Public Offering of Securities
2026-05-19 11:00 · Yahoo
Medicenna Announces the Launch of a Marketed Public Offering of Securities
2026-05-13 20:01 · Yahoo
Medicenna Says First Patient Dosed in NEO-CYT Study
2026-05-12 12:10 · Yahoo
Medicenna and Fondazione Melanoma Onlus Announce First Patient Dosed in the NEO-CYT Study of MDNA11 in Neoadjuvant Melanoma
2026-05-12 11:00 · Yahoo
Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026
2026-04-30 11:30 · Yahoo
TSX Penny Stocks To Watch In April 2026
2026-04-27 19:05 · Yahoo
Medicenna Therapeutics Presents "Positive" MDNA113 Data at AACR Meeting
2026-04-21 11:45 · Yahoo
Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026
2026-04-21 11:30 · Yahoo
Medicenna to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
2026-04-14 11:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.